Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix Quadrivalent in Children Previously in Study 115345
NCT01702454Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2012
- Primary completion
- May 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
Phase 3, open-label trial of influenza virus vaccine, quadrivalent, split virion in influenza (2 arms), sponsored by GSK. Primary endpoints: Serum Hemagglutination Inhibition (HI) Antibody Titers at Day 7, Number of Seropositive Subjects at Day 7 and 3 more. Started Oct 2012; status: completed.
02
Drugs
influenza virus vaccine, quadrivalent, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01702454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702454.